Crossref
Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma
Iranian Journal of Blood and Cancer · 2022
DOI: 10.58209/ijbc.14.3.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Mahdieh Hamidfar und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hamidfar, M., Sheikhpour, E., Tafti, M. A., Daneshmand, F., & Abedinzadeh, M. (2022). Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.3.11
Vancouver
Hamidfar M, Sheikhpour E, Tafti MA, Daneshmand F, Abedinzadeh M. Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.3.11
BibTeX
@article{Hamidfar2022,
author = {Hamidfar, Mahdieh and Sheikhpour, Elnaz and Tafti, Mahmood Akhavan and Daneshmand, Fateme and Abedinzadeh, Mehdi},
title = {Evaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma},
journal = {Iranian Journal of Blood and Cancer},
year = {2022},
doi = {10.58209/ijbc.14.3.11}
}
EUVIMED